12/19
07:42 am
cccc
Rating for CCCC
Low
Report
Rating for CCCC
12/19
07:42 am
cccc
Rating for CCCC
Low
Report
Rating for CCCC
12/19
07:42 am
cccc
C4 Therapeutics, Inc. (NASDAQ: CCCC) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $12.00 price target on the stock, up previously from $8.00.
Low
Report
C4 Therapeutics, Inc. (NASDAQ: CCCC) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $12.00 price target on the stock, up previously from $8.00.
12/19
05:39 am
cccc
C4 Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
Medium
Report
C4 Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
12/19
05:39 am
cccc
C4 Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
Medium
Report
C4 Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
11/18
10:22 am
cccc
Rating for CCCC
Low
Report
Rating for CCCC
11/18
08:50 am
cccc
C4 Therapeutics, Inc. (NASDAQ: CCCC) is now covered by analysts at Stephens. They set an "equal weight" rating and a $4.00 price target on the stock.
Medium
Report
C4 Therapeutics, Inc. (NASDAQ: CCCC) is now covered by analysts at Stephens. They set an "equal weight" rating and a $4.00 price target on the stock.
11/18
08:50 am
cccc
C4 Therapeutics, Inc. (NASDAQ: CCCC) is now covered by analysts at Stephens. They set an "equal weight" rating and a $4.00 price target on the stock.
Medium
Report
C4 Therapeutics, Inc. (NASDAQ: CCCC) is now covered by analysts at Stephens. They set an "equal weight" rating and a $4.00 price target on the stock.